These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 3990175)

  • 1. [Differential use of diet and drugs in dyslipoproteinemias].
    Lipovetskiĭ BM; Triufanov VF; Teriukova NP
    Klin Med (Mosk); 1985 Jan; 63(1):116-20. PubMed ID: 3990175
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of low dose omega-3-fatty acids on blood pressure, blood lipids and blood fluidity in patients with hyperlipoproteinemia].
    Staedt U; Kirschstein W; Simianer S; Kuhn C; Aufenanger J; Holm E
    Vasa Suppl; 1989; 27():253-4. PubMed ID: 2623506
    [No Abstract]   [Full Text] [Related]  

  • 3. Therapy of hyperlipidemic states.
    Havel RJ; Kane JP
    Annu Rev Med; 1982; 33():417-33. PubMed ID: 7044276
    [No Abstract]   [Full Text] [Related]  

  • 4. The influence of a no-sugar diet on the composition of VLDL-fraction in patients with idiopathic hyperlipoprotenemia of type IIb and IV.
    Cybulska B; Naruszewicz M; Kłosiewicz-Latoszek L; Szostak WB; Chotkowska E
    Mater Med Pol; 1980; 12(4):286-92. PubMed ID: 7266054
    [No Abstract]   [Full Text] [Related]  

  • 5. [Comparative study of drug and dietary correction of dyslipoproteinemias among the population].
    Khaltaev NG; Kazanskaia AI; Kuts GG; Verbitskaia AI; Bulin VA
    Kardiologiia; 1984 Nov; 24(11):15-20. PubMed ID: 6521200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Consumption of fish fats: effect on plasma lipids].
    Oliván B; Tejerina E; Rodríguez-Coira A; Rubio MA; Cabrerizo L; Romeo S
    Rev Clin Esp; 1988 Dec; 183(9):452-4. PubMed ID: 3238097
    [No Abstract]   [Full Text] [Related]  

  • 7. [Subfractions of HDL cholesterol. Occurrence in hyperlipoproteinemia type IIa and IV].
    Mertz DP; Thuilot G; Bürvenich K
    Fortschr Med; 1986 Jul; 104(26):508-10. PubMed ID: 3744260
    [No Abstract]   [Full Text] [Related]  

  • 8. Cardiovascular risk in patients with treated familial hypercholesterolaemia and patients with severe hypertriglyceridaemia.
    Way BP; Ball MJ; Thorogood M; Cobbe SM; Mann JI
    J R Soc Med; 1986 Jul; 79(7):391-4. PubMed ID: 3746800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelets intravascular coagulation and fibrinolysis in hyperlipidaemias: relationship to thrombo-embolic complications.
    Carvalho AC; Lees RS
    Acta Med Scand Suppl; 1980; 642():101-12. PubMed ID: 6935936
    [No Abstract]   [Full Text] [Related]  

  • 10. Fibrinogen catabolism in patients with type II and type IV hyperlipidemia. Effect of dietary and clofibrate treatment on laboratory findings.
    Fletcher A; Alkjaersig N; Schonfeld G; Witztum J
    Arteriosclerosis; 1981; 1(3):202-9. PubMed ID: 7295193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term effect of a low-fat, high-carbohydrate diet on plasma lipids of patients affected by familial endogenous hypertriglyceridemia.
    Cominacini L; Zocca I; Garbin U; Davoli A; Compri R; Brunetti L; Bosello O
    Am J Clin Nutr; 1988 Jul; 48(1):57-65. PubMed ID: 3389330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathogenesis and management of lipoprotein disorders.
    Schaefer EJ; Levy RI
    N Engl J Med; 1985 May; 312(20):1300-10. PubMed ID: 3887163
    [No Abstract]   [Full Text] [Related]  

  • 13. [Plafibride treatment of hyperlipidemias type II and IV].
    Soler J; Vinzia C; Gómez JM; Morató J
    Med Clin (Barc); 1984 May; 82(19):840-2. PubMed ID: 6738212
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of omega-3-fatty acids on lipoprotein metabolism. Different effects in various phenotypes].
    Singer P; Hüve J
    Fortschr Med; 1991 Aug; 109(24):476-9. PubMed ID: 1937329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of a clofibrate-inositol nicotinate combination on lipids and lipoproteins in primary hyperlipoproteinemia of types IIa, IV and V].
    Hutt V; Wechsler JG; Klör HU; Ditschuneit H
    Arzneimittelforschung; 1983; 33(5):776-9. PubMed ID: 6683558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of etofylline clofibrate on the composition of lipoproteins in hyperlipidaemia type IIb and IV (author's transl)].
    Ditschuneit HH; Hutt V; Klör HU; Ditschuneit H
    Arzneimittelforschung; 1980; 30(11b):2063-7. PubMed ID: 7194061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Musculoskeletal symptoms in patients with primary hyperlipoproteinemia. A prelimary study].
    Brekke SE; Kogstad OA
    Tidsskr Nor Laegeforen; 1979 Oct; 99(29):1444-6. PubMed ID: 516016
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of type II and type IV Fredrickson's hyperlipoproteinemia.
    Crepaldi G; Fellin R; Briani G
    Adv Exp Med Biol; 1973; 38():199-217. PubMed ID: 4766527
    [No Abstract]   [Full Text] [Related]  

  • 19. The effect of n-3 fatty acids on lipids and haemostasis in patients with type IIa and type IV hyperlipidaemia.
    Schmidt EB; Ernst E; Varming K; Pedersen JO; Dyerberg J
    Thromb Haemost; 1989 Sep; 62(2):797-801. PubMed ID: 2814927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of partial ileoshunting on hyperlipoproteinemia in patients with atherosclerosis].
    Sedletskiĭ IuI
    Vestn Khir Im I I Grek; 1985 Aug; 135(8):48-51. PubMed ID: 4060509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.